| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |